MedTrace Logo

Neurodynamic Tensioning Plus Grip Strengthening for Hand Grip Strength

NCT07762937 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-08-13

No results posted yet for this study

Summary

This randomized controlled trial will investigate whether adding neurodynamic tensioning to a grip strengthening program provides additional improvements in hand grip strength in healthy adults. Sixty participants aged 18 to 40 years will be randomly assigned to two groups. Both groups will perform a standardized grip strengthening program for six weeks, three days per week. The experimental group will additionally receive neurodynamic tensioning exercises targeting the median and ulnar nerves. Hand grip strength will be assessed at baseline, week 3, and week 6. The study aims to determine whether neurodynamic tensioning provides additional benefit beyond grip strengthening alone.

Conditions

  • Hand
  • Grip
  • Nerve

Interventions

OTHER

Grip Strengthening Program

Participants will perform a standardized grip strengthening program using an adjustable hand gripper with the dominant hand for six weeks, three sessions per week. Each session will consist of 3 sets of 8-12 repetitions, with approximately 2 seconds of gripping and 2 seconds of relaxation per repetition. Rest periods of 60-90 seconds will be provided between sets. Resistance will be progressively adjusted according to performance and perceived exertion.

OTHER

Neurodynamic Tensioning

Neurodynamic tensioning targeting the median and ulnar nerves will be applied before the grip strengthening program. For each nerve, 3 sets of 10 repetitions will be performed, with each repetition consisting of approximately 4-5 seconds of controlled rhythmic tensioning. A 30-second rest period will be provided between sets. The technique will be performed within pain-free limits, producing only a mild stretching sensation.

Sponsors & Collaborators

  • Tokat Gaziosmanpasa University

    lead OTHER

Principal Investigators

  • Uğur Sözlü, PhD · Tokat Gaziosmanpaşa Üniversitesi

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-15
Primary Completion
2027-01-15
Completion
2027-01-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07762937 on ClinicalTrials.gov